Advances in Treatments of Myeloma
(2023)
Advances in Treatments of Myeloma: pp.
-.
Chapter 5
Immune Responses to COVID-19 Booster Vaccinations in Intensively Anti-CD38 Antibody Treated Patients with Ultra-high-risk Multiple Myeloma: Results from the Myeloma UK (MUK) nine OPTIMUM Trial